Samrat Pharmachem Ltd. benchmarking: Perfomance to industry peers

Financial

	Samrat Pharmachem	Onyx Biotec	Biofil Chem & Pharma
Operational Metrics
Financials
5 yr Average ROE	18.86 %	13.47 %	4.39 %
5yr average Equity Multiplier	1.83	2.51	2.06
5yr Average Asset Turnover Ratio	2.61	0.82	0.95
5yr Avg Net Profit Margin	3.87 %	6.72 %	2.38 %
Price to Book	1.02	1.2	2.86
P/E	45.94	13.54	21.26
5yr Avg Cash Conversion Cycle	58.79 Days	36.81 Days	75.63 Days
Inventory Days	28.98 Days	48.71 Days	28.27 Days
Days Receivable	80.32 Days	104.89 Days	389.8 Days
Days Payable	46.76 Days	101.26 Days	203.89 Days
5yr Average Interest Coverage Ratio	16.47	4.89	23.53
5yr Avg ROCE	27.43 %	12.63 %	6.37 %
5yr Avg Operating Profit Margin	5.58 %	14.14 %	3.78 %
5 yr average Debt to Equity	0.21	0.95	0.03
5yr CAGR Net Profit	5.93 %	8.12 %	-14.7 %
5yr Average Return on Assets	10.3 %	5.64 %	2.37 %
Shareholdings
Promoter Holding	49.09 %	65.1 %	46.79 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.45 %	0.0	-0.03 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Samrat Pharmachem	Onyx Biotec	Biofil Chem & Pharma
Product Wise Break-Up	Product Wise Break-Up Dry Powder Syrup 0 Dry Powder Injections 0 Sterile Water Injections 0 Chemicals Div 0 Pharma Div 0 Others 100	Product Wise Break-Up Pharma Div 0 Dry Powder Syrup 2.25 Dry Powder Injections 38.17 Chemicals Div 0 Sterile Water Injections 59.49 Others 0.09	Product Wise Break-Up Pharmaceuticals 89.69 Dry Powder Syrup 0 Dry Powder Injections 0 Chemicals 10.31 Sterile Water Injections 0